Professor of Medicine, Washington University St Louis
Endocrinology
Dr. Philip E. Cryer, MD
|
|
Give Review
Doctor Philip E. Cryer, MD works in the field of Endocrinology. He went to Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine has a rank of 19 in research and a 29 in primary care He received awards:"CMS Meaningful Use Stage 1 Certification" and "Whos Who in Medicine and Healthcare". Philip E. Cryer, MD is also a published physician. He has 49 paper published. The most recent paper is: Glycemic Goals in Diabetes: Trade-off Between Glycemic Control and Iatrogenic Hypoglycemia. He is registered with Medicare.
Publications
- Glycemic Goals in Diabetes: Trade-off Between Glycemic Control and Iatrogenic Hypoglycemia.
- Lactate and the mechanism of hypoglycemia-associated autonomic failure in Diabetes.
- Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 Diabetes mellitus.
- Mechanisms of hypoglycemia-associated autonomic failure in Diabetes.
- Thalamic activation during slightly subphysiological glycemia in humans.
- Glucagon in the Pathogenesis of Hypoglycemia and Hyperglycemia in Diabetes.
- Death during Intensive Glycemic Therapy of Diabetes: Mechanisms and Implications.
- Partial inhibition of insulin secretion results in glucose intolerance but not hyperglucagonemia.
- Adrenergic mediation of Hypoglycemia-associated autonomic failure.
- Elimination of hypoglycemia from the lives of people affected by Diabetes.
- Insulin reciprocally regulates glucagon secretion in humans.
- Glucagon supports postabsorptive plasma glucose concentrations in humans With biologically optimal insulin levels.
- Hypoglycemia in type 1 Diabetes mellitus.
- Beta-cell-mediated signaling predominates over direct alpha-cell signaling in the regulation of glucagon secretion in humans.
- Exercise-related hypoglycemia-associated autonomic failure in Diabetes.
- Evaluation and management of adult hypoglycemic Disorders: an Endocrine Society Clinical Practice Guideline.
- Attenuated sympathoadrenal responses, but not severe hypoglycemia, during aggressive glycemic therapy of early type 2 Diabetes.
- The barrier of hypoglycemia in Diabetes.
- Terbutaline and the prevention of nocturnal hypoglycemia in type 1 Diabetes.
- Hypoglycemia: still the limiting factor in the glycemic management of Diabetes.
- Attenuation of counterregulatory responses to recurrent Hypoglycemia by active thalamic inhibition: a mechanism for Hypoglycemia-associated autonomic failure.
- Basal insulin, glucagon, and growth hormone replacement.
- Glucagon, in concert With insulin, supports the postabsorptive plasma glucose concentration in humans.
- Hypoglycemia, functional brain failure, and brain death.
- PPARalpha activation elevates blood pressure and does not correct glucocorticoid-induced insulin resistance in humans.
- Nocturnal hypoglycemia in type 1 Diabetes: an assessment of preventive bedtime treatments.
- Mechanisms of sympathoadrenal failure and hypoglycemia in Diabetes.
- Multiple defects in counterregulation of hypoglycemia in modestly advanced type 2 Diabetes mellitus.
- Effects of glimepiride and glyburide on glucose counterregulation and recovery from Hypoglycemia.
- Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in Diabetes.
- Increasing the decrement in insulin secretion improves glucagon responses to hypoglycemia in advanced type 2 Diabetes.
- Maintenance of the postabsorptive plasma glucose concentration: insulin or insulin plus glucagon?
- Role of the decrement in intraislet insulin for the glucagon response to Hypoglycemia in humans.
- Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient Diabetes: documentation of the intrai...
- Mechanism, temporal patterns, and magnitudes of the metabolic responses to the KATP channel agonist diazoxide.
- Hypoglycemia in type 2 Diabetes.
- Hypoglycemia and the sympathoadRenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation.
- Diverse causes of hypoglycemia-associated autonomic failure in Diabetes.
- Activation of human medial prefrontal cortex during autonomic responses to Hypoglycemia.
- Cortisol elevations comparable to those that occur during Hypoglycemia do not cause Hypoglycemia-associated autonomic failure.
- Hypoglycemia in Diabetes.
- Renal compensation for impaired hepatic glucose release during hypoglycemia in type 2 Diabetes: further evidence for hepatorenal reciprocity.
- Sleep-related hypoglycemia-associated autonomic failure in type 1 Diabetes: reduced awakening from sleep during hypoglycemia.
- Limited impact of vigorous exercise on defenses against Hypoglycemia: relevance to Hypoglycemia-associated autonomic failure.
- Intraislet hyperinsulinemia prevents the glucagon response to Hypoglycemia despite an intact autonomic response.
- Elevated endogenous cortisol reduces autonomic neuroendocrine and symptom responses to subsequent Hypoglycemia.
- Hypoglycemia-associated autonomic failure in advanced type 2 Diabetes.
- Hypoglycemia-associated autonomic failure in Diabetes.
Schools
Northwestern Center Feinberg School of Medicine
Barnes Jewish Hospital
Wash Barnes Hospital
Conditions Treated
- Abnormal Thyroid
- Calcium Metabolism Disorders
- Diabetes Type 1
- Diabetes Type 2
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Whos Who in Medicine and Healthcare
Education
-
Washington University - Barnes-Jewish Hospital -
Northwestern University Feinberg School of Medicine
Hospital
-
Barnes-Jewish Hospital -
St. Louis Children's Hospital
Drug Facts
| NPI NUMBER | 1841218310 | |
| NPPES Provider LastName | CRYER | |
| NPPES Provider FirstName | PHILIP | |
| NPPES Provider ZIPCode | 631101020 | |
| NPPES Provider State | MO | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 142.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1841218310 |
| Last Name Of The Provider | CRYER |
| First Name Of The Provider | PHILIP |
| View All |
Similar Doctors
|
|
Dr. Stephen J. Giddings, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Agusta Olafsdottir, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Simon J. Fisher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan D. Bortz, MD |
|
|
Dr. William E. Clutter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paraskevi Mentzelopoulos, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Natalya Rukhman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Irini E. Veronikis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. K G. Thampy, MD
This Doctor is OpenDoctor Recommended.
|